the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia

we propose this study and try to find out possible clinical applicable non-invasive imaging indices or its combination with the laboratory indices to predict the status of hepatic fibrosis in BA patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients.

Age range

10 day–30 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pathological proved diagnosis of biliary atresia, and without other distinct abnormality or malformations. All had undergone Kasai portoenterostomy. All of them received abdominal MRI study.

Exclusion criteria

absence of laboratory data required.

Treatment and study plan

Primary outcomes

pathologic METAVIR fibrosis score

Time frame: 1 month

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

the Correlation Between Hepatic Fibrotic Scores and ADC and Other Non-invasive Indicators in Patients With Biliary Atresia

Important dates

Study start: 2008
Primary completion: 2016
First posted: Jul 28, 2016
Registry last updated: Jul 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.